RNAC
Cartesian Therapeutics, Inc. Common Stock
$5.91
0.51%
+0.03
Notify me if price changes either direction
Buy RNAC stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
155.9M
Enterprise value
42.6M
Trailing PE
1.9756098
Forward PE
-3.4615383
PEG Ratio
0.08929756296
Enterprise to EBITDA
-0.509
Enterprise to revenue
15.236
Price to book MRQ
-4.2728777594085
Price to sales TTM
55.444332
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
2.8M
EBITDA
-83746000
Diluted EPS TTM
-5.02
Total Cash (MRQ)
125.1M
Current ratio (MRQ)
8.655
Operating Cash Flow (TTM)
-73941000
RNAC trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
March 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
